Molecular Diagnostics Europe 2017 | Immune Monitoring in Next Generation Immunotherapy Trials episode artwork

EPISODE · Mar 16, 2017 · 6 MIN

Molecular Diagnostics Europe 2017 | Immune Monitoring in Next Generation Immunotherapy Trials

from CHI Podcasts · host Cambridge Healthtech Podcasts

Dr. Thomas Kleen outlines some of the challenges biomarker discovery, discusses his role in the STIC/FDA Immunotherapy Biomarkers Taskforce, and the focus of his work at Epiontis as the Executive Vice President of Immune Monitoring in this podcast for the Biomarkers for Immunotherapy conference at Molecular Diagnostics Europe Summit. To learn more, please visit http://www.MolecularDXEurope.com/Immunotherapy-Biomarkers/

Episode metadata supplied by the publisher feed · Published Mar 16, 2017

Embed this episode

NOW PLAYING

Molecular Diagnostics Europe 2017 | Immune Monitoring in Next Generation Immunotherapy Trials

0:00 6:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 6 minutes long.

When was this CHI Podcasts episode published?

This episode was published on March 16, 2017.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!